Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:HMMJ

Horizon's Medical Marijuana (HMMJ.TO)

7.22
-0.06 (0.82%)
as of Jun 15, 2026, 7:59:40 pm Market Open.
114 watching
0
Investor Insights
star iconJun 15, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

Horizon Medical Marijuana (HMMJ-T) has captured the attention of several experts, particularly regarding its potential for significant growth. There is optimism surrounding the possibility of new banking legislation that could greatly affect the company's fortunes, with some experts noting strong bipartisan support for such a change. The stock is characterized by high volatility, suggesting that it can experience rapid changes in price, which may present both risks and opportunities for investors. The consensus is that Horizon Medical Marijuana could be a standout performer, with the potential to become a multi-bagger investment, possibly offering returns that could multiply by 2, 4, 5, or even 10 times its current value. This combination of legislative prospects and market dynamics makes it a compelling option for investors seeking substantial gains in the marijuana sector.

consensus icon
Consensus
Positive
valuation icon
Valuation
Undervalued
review icon
Similar
APHA,APHA
RISKY

Marijuana. The ETF gives you the basket of securities. When you go into an area that is new, you are never going to buy these stocks cheap. We had high momentum and now it seems to have broken down. You have to manage risk carefully. Have a stop loss.

DON'T BUY

Good time to get in? His firm uses only ETFs. This is an example of where ETFs are not the way to go on themes. All the enthusiasm about marijuana is already baked in, so could sell off once it’s legal. Canopy Growth is the Phillip Morris of marijuana. Why pay the premium of the ETF, just buy Canopy Growth.

DON'T BUY

Right now he does not want exposure. He does not like the risk of the sector. We need to see this commodity legitimized. HMMJ-T is a speculation, not an investment. After the next recession, companies with no earnings get obliterated.

COMMENT

Cannabis or cannabis tech ETF? The problem with cannabis stocks are valuations--only one of the holdings in HMMJ has positive earnings. He's anticipating a lot of growth, like tech in 2000. He doesn't know enough about the tech behind growing cannabis, but look at ROBO-T and other AI ETFs.

COMMENT

Baytex versus HMMJ. There is no correlation between these two. BTE-T looks fine technically as he thinks WTI should return back above $70 before year end. The recent breakout is positive, especially since it was basing around $3.50. He does not understand the cannabis market, so can’t render an opinion. “You can’t make an iPhone in your basement, but you can grow marijuana.” He thinks demand is already met, so he would only hold a small lot of HMMJ-T to talk about at cocktail parties.

BUY

He'd rather buy HMMJ--individual companies are too volatile. Looking ahead: the price of bud will go lower. The next stage is profitability, especially when the big banks get involved. That will be a game-changer and exciting, but this will take time.

DON'T BUY

It's the prominent cannabis ETF, but the cannabis sector is all about consolidation and swapping paper. There are a lot of unknowns and nobody is making any money. Cannabis is a gamble and he avoids it.

RISKY

This ETF is better than holding any individual company as it offers better diversification including some of the smaller producers. His view that these niche sector ETFs should be viewed as a speculative holding as many of the holdings are not even showing positive earnings yet. MER is 0.75%. It is a little early to consider this as a long term holding.

DON'T BUY

He's got nothing against it. But there's already a lot of price appreciation in cannabis, like the run-up in dotcom stocks in the late-90s. The value of stocks went so far ahead that tech stocks went nowhere for 10 years. Vices do well. Don't
chase this sector. These stocks are ahead of themselves.

DON'T BUY

It is 100% speculative. You have to be ready for a bumpy ride. We saw a big M&A transaction today and you will see a lot more of them. There will be a handful of survivors. This is incredibly overvalued today. If the US went for legal weed use, it would be a game changer. Wait until it is a value play after the next recession.

DON'T BUY

Marijuana. If you are going to play the sector it is a momentum trade and the ETF is the way to go. The sector is tremendously ahead of itself and there is a lot of speculation in these stocks. We will not know for a year after it becomes legal, how these companies are going to do. You could get a lot of price volatility.

DON'T BUY

You have to remember, this ETF and the companies in it, none are making any money. Secondly, we don't know what price this is going to come out at or the distribution network. We don't know what the margins of profit are going to be. On that basis, he won't buy this. He is an investor, not a gambler. If you wouldn't take your money to a gambling casino, then don't put it in this stock.

COMMENT

Very dubious about the whole marijuana sector. It's an area where you can sort of put your sign up saying we are now in the marijuana business, and away you go. There are some big legitimate companies that are going to do well, but we really don't know exactly how well they are going to do. He is not sure they will be very profitable.

COMMENT

There is a lot of emerging names in the marijuana space. It is very tricky, because we are still in early days in the marijuana market. It’s hard to tell who is going to be the winner and who is going to be the loser, so owning the ETF is probably the right way to go. The stock can be volatile, so if you have the stomach for it and you feel it is an area you can feel confident about, you are probably better off playing this then picking an individual producer or 2.

COMMENT

To him, marijuana is an extremely risky industry, and can’t make heads or tails of the valuation of these companies.

Showing 31 to 45 of 61 entries